An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 761125
Company: NOVARTIS PHARMS CORP

Products on BLA 761125

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BEOVU	brolucizumab-dbll	6MG/0.05ML	INJECTABLE; INTRAVITREAL	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 761125

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/07/2019	ORIG-1	Approval		N/A	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761125s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761125Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761125_Orig1_toc.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/29/2024	SUPPL-21	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761125s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761125Orig1s021ltr.pdf
09/28/2023	SUPPL-20	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761125s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761125Orig1s020ltr.pdf
12/19/2022	SUPPL-17	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761125Orig1s017ltr.pdf
02/18/2022	SUPPL-13	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s010s012s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761125Orig1s010, s012, s013ltr.pdf
02/18/2022	SUPPL-12	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s010s012s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761125Orig1s010, s012, s013ltr.pdf
02/18/2022	SUPPL-10	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s010s012s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761125Orig1s010, s012, s013ltr.pdf
05/27/2022	SUPPL-8	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761125Orig1s008ltr.pdf
06/09/2020	SUPPL-4	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761125s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761125Orig1s004ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761125Orig1s004.pdf
03/09/2022	SUPPL-2	Supplement		Label is not available on this site.

Labels for BLA 761125

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/29/2024	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761125s021lbl.pdf
09/28/2023	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761125s020lbl.pdf
12/19/2022	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s017lbl.pdf
05/27/2022	SUPPL-8	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s008lbl.pdf
02/18/2022	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s010s012s013lbl.pdf
02/18/2022	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s010s012s013lbl.pdf
02/18/2022	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s010s012s013lbl.pdf
06/09/2020	SUPPL-4	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761125s004lbl.pdf
10/07/2019	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761125s000lbl.pdf

Top